Skip to main content
Nephrocare Health Services Limited logo

Nephrocare Health Services Limited — Investor Relations & Filings

Ticker · NEPHROPLUS ISIN · INE428V01029 LEI · 8945009XZNBR6GO8SU26 BSE.NS Human health and social work activities
Open in API
Filings indexed 98 across all filing types
Latest filing 2026-05-27 Call Transcript
Country IN India
Listing BSE.NS NEPHROPLUS

About Nephrocare Health Services Limited

https://www.nephrocareindia.com/

Nephrocare Health Services Limited, operating primarily under the brand NephroPlus, is a specialized provider of comprehensive renal care services. The organization manages an extensive network of dialysis centers, offering clinical solutions such as hemodialysis, peritoneal dialysis, and nocturnal dialysis. Its service model emphasizes standardized clinical protocols, advanced water treatment systems, and patient-centric initiatives including home dialysis and holiday dialysis programs. The company partners with medical institutions through various management models and standalone clinics to increase accessibility for patients with end-stage renal disease. By integrating technology-driven monitoring and specialized training for clinical staff, the entity focuses on enhancing clinical outcomes and the overall quality of life for individuals requiring long-term kidney replacement therapy.

Recent filings

Filing Released Lang Actions
Please find enclosed herewith Transcript for the Investor Earnings Call held on May 20, 2026.
Call Transcript Classification · 95% confidence The document is a full text transcript of the Q4 & FY26 earnings conference call, including opening remarks, management discussion and Q&A, filed under Regulation 30. It is clearly a conference call transcript rather than an earnings release summary or notice of report publication.
2026-05-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is the full text of Nephrocare Health Services Limited’s Q4 & FY26 earnings conference call transcript, including the cover letter to the stock exchanges, moderator introduction, management presentations and Q&A. It is not a brief announcement of a report or an officer certification, but the full transcript of the earnings call. This matches the definition of a Call Transcript (CT).
2026-05-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 90% confidence The document is a formal intimation under SEBI Listing Regulations of the schedule of analyst/institutional investor meetings. It does not contain a financial report, presentation content, or actual financial data. It is a regulatory announcement to stock exchanges. Therefore, it fits into the fallback category for general regulatory announcements and compliance filings.
2026-05-27 English
Pursuant to Regulation 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an Investor Conference Call as per the disclosure enclosed herewith.
Regulatory Filings Classification · 92% confidence The document is an exchange filing under SEBI Listing Regulations 2015 notifying the schedule of analyst/institutional investor meetings. It does not contain any financial statements, investor presentation content, or substantive report. It is a compliance/regulatory announcement to stock exchanges. Therefore it falls under the general “Regulatory Filings” category (RNS) as a fallback for miscellaneous regulatory disclosures.
2026-05-27 English
Pursuant to Regulation 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an Investor Conference Call as per the disclosure enclosed herewith
Regulatory Filings Classification · 80% confidence The document is an SEBI Listing Regulation 30 disclosure notifying stock exchanges and investors about the company’s schedule for analyst/institutional investor meetings. It is neither a financial report nor a presentation itself, but a regulatory announcement of an upcoming investor meeting, falling under general regulatory filings disclosure.
2026-05-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 75% confidence The document is an intimation to stock exchanges under SEBI Listing Regulations about the schedule of analyst/institutional investor meetings. It does not contain financial results, management discussions, or a presentation itself, but is a regulatory announcement of an event. It therefore fits the “Regulatory Filings” category (RNS) as a general regulatory announcement rather than a financial report or earnings release.
2026-05-27 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.